Common use of Special Mandatory Conversion Clause in Contracts

Special Mandatory Conversion. In the event that the Preferred Stock held by an Investor is converted into Common Stock pursuant to a Special Mandatory Conversion, such person shall cease to be an Investor under this Agreement and shall cease to be entitled to any of the rights and privileges granted to an Investor pursuant to this Agreement. The parties hereto have duly executed this SECOND AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT by their respective officers thereunto duly authorized as of the date set forth in the first paragraph hereof. COMPANY: INOZYME PHARMA, INC. By: /s/ Xxxx Xxxxx Name: Xxxx Xxxxx Title: Chief Executive Officer Address: 000 Xxxxxx Xxxxxx 0xx Xxxxx Xxxxxx, Xxxxxxxxxxxxx 00000 [**] The parties hereto have duly executed this SECOND AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT by their respective officers thereunto duly authorized or by their duly acting representatives acting by their respective officers thereunto duly authorized as of the date set forth in the first paragraph hereof. INVESTORS: Pivotal bioVenture Partners Fund I, L.P. By: Pivotal bioVenture Partners Fund I G.P., L.P., its general partner By: Pivotal bioVenture Partners Fund I U.G.P. Ltd, its general partner By: /s/ Xxxxxx Xxxxxxx Name: Xxxxxx Xxxxxxx Title: Managing Partner Notice provisions: [**] The parties hereto have duly executed this SECOND AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT by their respective officers thereunto duly authorized or by their duly acting representatives acting by their respective officers thereunto duly authorized as of the date set forth in the first paragraph hereof. INVESTORS: LONGITUDE VENTURE PARTNERS III, L.P. By: Longitude Capital Partners III, LLC Its: General Partner Signatures: /s/ Xxxxxxx Xxxxxxx Print Name: Xxxxxxx Xxxxxxx Title: Managing Member The parties hereto have duly executed this SECOND AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT by their respective officers thereunto duly authorized or by their duly acting representatives acting by their respective officers thereunto duly authorized as of the date set forth in the first paragraph hereof. INVESTORS: NEW ENTERPRISE ASSOCIATES 15, L.P. By: NEA Partners 15, L.P. Its: General Partner By: NEA 15 GP, LLC Its: General Partner Signature: /s/ Xxxxx Xxxxxx Print Name: Xxxxx Xxxxxx Title: Chief Legal Officer NEA VENTURES 2016, LIMITED PARTNERSHIP Signature: /s/ Xxxxx Xxxxxx Print Name: Xxxxx Xxxxxx Title: Chief Legal Officer The parties hereto have duly executed this SECOND AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT by their respective officers thereunto duly authorized or by their duly acting representatives acting by their respective officers thereunto duly authorized as of the date set forth in the first paragraph hereof. INVESTORS: NOVO HOLDINGS A/S Signature: /s/ Xxxxxx Dyrberg Print Name: Xxxxxx Dyrberg, under specific power of attorney Title: Managing Partner The parties hereto have duly executed this SECOND AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT by their respective officers thereunto duly authorized or by their duly acting representatives acting by their respective officers thereunto duly authorized as of the date set forth in the first paragraph hereof. INVESTORS: AVENTIS INC. Signature: /s/ Chan X. Xxx Print Name: Chan X. Xxx Print Title: Vice President The parties hereto have duly executed this SECOND AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT by their respective officers thereunto duly authorized or by their duly acting representatives acting by their respective officers thereunto duly authorized as of the date set forth in the first paragraph hereof. INVESTORS: Signature: /s/ Xxxxxx Xxxxxxxxxxxx Print Name: Xxxxxx Xxxxxxxxxxxx The parties hereto have duly executed this SECOND AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT by their respective officers thereunto duly authorized or by their duly acting representatives acting by their respective officers thereunto duly authorized as of the date set forth in the first paragraph hereof. INVESTORS: XXXXXX XXXXXXX TRUST DATED NOV. 12, 2014 Signature: /s/ Xxxxxx Xxxxxxx Print Name: Xxxxxx Xxxxxxx Title: Trustee INOZYME PHARMA, INC. Counterpart Signature Page By executing and delivering this signature page, the undersigned (the “Investor”) hereby joins in, becomes a party to and agrees to be bound by the terms and conditions of: